<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2002-05-02" modified="2017-05-10" version="186">
<accession>O43353</accession>
<accession>B7Z748</accession>
<accession>Q6UWF0</accession>
<name>RIPK2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Receptor-interacting serine/threonine-protein kinase 2</fullName>
<ecNumber>2.7.11.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>CARD-containing interleukin-1 beta-converting enzyme-associated kinase</fullName>
<shortName>CARD-containing IL-1 beta ICE-kinase</shortName>
</alternativeName>
<alternativeName>
<fullName>RIP-like-interacting CLARP kinase</fullName>
</alternativeName>
<alternativeName>
<fullName>Receptor-interacting protein 2</fullName>
<shortName>RIP-2</shortName>
</alternativeName>
<alternativeName>
<fullName>Tyrosine-protein kinase RIPK2</fullName>
<ecNumber>2.7.10.2</ecNumber>
</alternativeName>
</protein>
<gene>
<name type="primary">RIPK2</name>
<name type="synonym">CARDIAK</name>
<name type="synonym">RICK</name>
<name type="synonym">RIP2</name>
<name type="ORF">UNQ277/PRO314/PRO34092</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="12296" last="12300">
<title>RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis.</title>
<authorList>
<person name="Inohara N."/>
<person name="del Peso L."/>
<person name="Koseki T."/>
<person name="Chen S."/>
<person name="Nunez G."/>
</authorList>
<dbReference type="PubMed" id="9575181"/>
<dbReference type="DOI" id="10.1074/jbc.273.20.12296"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>MUTAGENESIS OF LYS-47</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="16968" last="16975">
<title>RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase.</title>
<authorList>
<person name="McCarthy J.V."/>
<person name="Ni J."/>
<person name="Dixit V.M."/>
</authorList>
<dbReference type="PubMed" id="9642260"/>
<dbReference type="DOI" id="10.1074/jbc.273.27.16968"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>MUTAGENESIS OF LYS-47</scope>
<source>
<tissue>Endothelial cell</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1998" name="Curr. Biol." volume="8" first="885" last="888">
<title>Identification of CARDIAK, a RIP-like kinase that associates with caspase-1.</title>
<authorList>
<person name="Thome M."/>
<person name="Hofmann K."/>
<person name="Burns K."/>
<person name="Martinon F."/>
<person name="Bodmer J.-L."/>
<person name="Mattmann C."/>
<person name="Tschopp J."/>
</authorList>
<dbReference type="PubMed" id="9705938"/>
<dbReference type="DOI" id="10.1016/S0960-9822(07)00352-1"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>MUTAGENESIS OF ASP-146</scope>
<source>
<tissue>Pancreatic adenocarcinoma</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2003" name="Genome Res." volume="13" first="2265" last="2270">
<title>The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.</title>
<authorList>
<person name="Clark H.F."/>
<person name="Gurney A.L."/>
<person name="Abaya E."/>
<person name="Baker K."/>
<person name="Baldwin D.T."/>
<person name="Brush J."/>
<person name="Chen J."/>
<person name="Chow B."/>
<person name="Chui C."/>
<person name="Crowley C."/>
<person name="Currell B."/>
<person name="Deuel B."/>
<person name="Dowd P."/>
<person name="Eaton D."/>
<person name="Foster J.S."/>
<person name="Grimaldi C."/>
<person name="Gu Q."/>
<person name="Hass P.E."/>
<person name="Heldens S."/>
<person name="Huang A."/>
<person name="Kim H.S."/>
<person name="Klimowski L."/>
<person name="Jin Y."/>
<person name="Johnson S."/>
<person name="Lee J."/>
<person name="Lewis L."/>
<person name="Liao D."/>
<person name="Mark M.R."/>
<person name="Robbie E."/>
<person name="Sanchez C."/>
<person name="Schoenfeld J."/>
<person name="Seshagiri S."/>
<person name="Simmons L."/>
<person name="Singh J."/>
<person name="Smith V."/>
<person name="Stinson J."/>
<person name="Vagts A."/>
<person name="Vandlen R.L."/>
<person name="Watanabe C."/>
<person name="Wieand D."/>
<person name="Woods K."/>
<person name="Xie M.-H."/>
<person name="Yansura D.G."/>
<person name="Yi S."/>
<person name="Yu G."/>
<person name="Yuan J."/>
<person name="Zhang M."/>
<person name="Zhang Z."/>
<person name="Goddard A.D."/>
<person name="Wood W.I."/>
<person name="Godowski P.J."/>
<person name="Gray A.M."/>
</authorList>
<dbReference type="PubMed" id="12975309"/>
<dbReference type="DOI" id="10.1101/gr.1293003"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Synovium</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2006" name="Nature" volume="439" first="331" last="335">
<title>DNA sequence and analysis of human chromosome 8.</title>
<authorList>
<person name="Nusbaum C."/>
<person name="Mikkelsen T.S."/>
<person name="Zody M.C."/>
<person name="Asakawa S."/>
<person name="Taudien S."/>
<person name="Garber M."/>
<person name="Kodira C.D."/>
<person name="Schueler M.G."/>
<person name="Shimizu A."/>
<person name="Whittaker C.A."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Dewar K."/>
<person name="FitzGerald M.G."/>
<person name="Yang X."/>
<person name="Allen N.R."/>
<person name="Anderson S."/>
<person name="Asakawa T."/>
<person name="Blechschmidt K."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Butler J."/>
<person name="Cook A."/>
<person name="Corum B."/>
<person name="DeArellano K."/>
<person name="DeCaprio D."/>
<person name="Dooley K.T."/>
<person name="Dorris L. III"/>
<person name="Engels R."/>
<person name="Gloeckner G."/>
<person name="Hafez N."/>
<person name="Hagopian D.S."/>
<person name="Hall J.L."/>
<person name="Ishikawa S.K."/>
<person name="Jaffe D.B."/>
<person name="Kamat A."/>
<person name="Kudoh J."/>
<person name="Lehmann R."/>
<person name="Lokitsang T."/>
<person name="Macdonald P."/>
<person name="Major J.E."/>
<person name="Matthews C.D."/>
<person name="Mauceli E."/>
<person name="Menzel U."/>
<person name="Mihalev A.H."/>
<person name="Minoshima S."/>
<person name="Murayama Y."/>
<person name="Naylor J.W."/>
<person name="Nicol R."/>
<person name="Nguyen C."/>
<person name="O'Leary S.B."/>
<person name="O'Neill K."/>
<person name="Parker S.C.J."/>
<person name="Polley A."/>
<person name="Raymond C.K."/>
<person name="Reichwald K."/>
<person name="Rodriguez J."/>
<person name="Sasaki T."/>
<person name="Schilhabel M."/>
<person name="Siddiqui R."/>
<person name="Smith C.L."/>
<person name="Sneddon T.P."/>
<person name="Talamas J.A."/>
<person name="Tenzin P."/>
<person name="Topham K."/>
<person name="Venkataraman V."/>
<person name="Wen G."/>
<person name="Yamazaki S."/>
<person name="Young S.K."/>
<person name="Zeng Q."/>
<person name="Zimmer A.R."/>
<person name="Rosenthal A."/>
<person name="Birren B.W."/>
<person name="Platzer M."/>
<person name="Shimizu N."/>
<person name="Lander E.S."/>
</authorList>
<dbReference type="PubMed" id="16421571"/>
<dbReference type="DOI" id="10.1038/nature04406"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="1570" last="1574">
<title>Rip2 participates in Bcl10 signaling and T-cell receptor-mediated NF-kappaB activation.</title>
<authorList>
<person name="Ruefli-Brasse A.A."/>
<person name="Lee W.P."/>
<person name="Hurst S."/>
<person name="Dixit V.M."/>
</authorList>
<dbReference type="PubMed" id="14638696"/>
<dbReference type="DOI" id="10.1074/jbc.C300460200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2006" name="Cell. Signal." volume="18" first="2223" last="2229">
<title>Identification of a regulatory autophosphorylation site in the serine-threonine kinase RIP2.</title>
<authorList>
<person name="Dorsch M."/>
<person name="Wang A."/>
<person name="Cheng H."/>
<person name="Lu C."/>
<person name="Bielecki A."/>
<person name="Charron K."/>
<person name="Clauser K."/>
<person name="Ren H."/>
<person name="Polakiewicz R.D."/>
<person name="Parsons T."/>
<person name="Li P."/>
<person name="Ocain T."/>
<person name="Xu Y."/>
</authorList>
<dbReference type="PubMed" id="16824733"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2006.05.005"/>
</citation>
<scope>PHOSPHORYLATION AT SER-176</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2007" name="J. Mol. Biol." volume="365" first="160" last="174">
<title>Solution structure of NOD1 CARD and mutational analysis of its interaction with the CARD of downstream kinase RICK.</title>
<authorList>
<person name="Manon F."/>
<person name="Favier A."/>
<person name="Nunez G."/>
<person name="Simorre J.P."/>
<person name="Cusack S."/>
</authorList>
<dbReference type="PubMed" id="17054981"/>
<dbReference type="DOI" id="10.1016/j.jmb.2006.09.067"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NOD1</scope>
<scope>MUTAGENESIS OF ARG-444; ARG-483 AND ARG-488</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2008" name="Curr. Biol." volume="18" first="1402" last="1408">
<title>MEKK4 sequesters RIP2 to dictate NOD2 signal specificity.</title>
<authorList>
<person name="Clark N.M."/>
<person name="Marinis J.M."/>
<person name="Cobb B.A."/>
<person name="Abbott D.W."/>
</authorList>
<dbReference type="PubMed" id="18775659"/>
<dbReference type="DOI" id="10.1016/j.cub.2008.07.084"/>
</citation>
<scope>INTERACTION WITH MAP3K4</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2008" name="EMBO J." volume="27" first="373" last="383">
<title>A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation.</title>
<authorList>
<person name="Hasegawa M."/>
<person name="Fujimoto Y."/>
<person name="Lucas P.C."/>
<person name="Nakano H."/>
<person name="Fukase K."/>
<person name="Nunez G."/>
<person name="Inohara N."/>
</authorList>
<dbReference type="PubMed" id="18079694"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601962"/>
</citation>
<scope>INTERACTION WITH IKBKG/NEMO AND MAP3K7/TAK1</scope>
<scope>FUNCTION</scope>
<scope>UBIQUITINATION AT LYS-209</scope>
<scope>MUTAGENESIS OF LYS-209</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-363; SER-527 AND SER-539</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-531</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="Curr. Biol." volume="19" first="1255" last="1263">
<title>ITCH K63-ubiquitinates the NOD2 binding protein, RIP2, to influence inflammatory signaling pathways.</title>
<authorList>
<person name="Tao M."/>
<person name="Scacheri P.C."/>
<person name="Marinis J.M."/>
<person name="Harhaj E.W."/>
<person name="Matesic L.E."/>
<person name="Abbott D.W."/>
</authorList>
<dbReference type="PubMed" id="19592251"/>
<dbReference type="DOI" id="10.1016/j.cub.2009.06.038"/>
</citation>
<scope>UBIQUITINATION BY ITCH</scope>
<scope>INTERACTION WITH NOD2</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="Immunity" volume="30" first="789" last="801">
<title>Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2.</title>
<authorList>
<person name="Bertrand M.J."/>
<person name="Doiron K."/>
<person name="Labbe K."/>
<person name="Korneluk R.G."/>
<person name="Barker P.A."/>
<person name="Saleh M."/>
</authorList>
<dbReference type="PubMed" id="19464198"/>
<dbReference type="DOI" id="10.1016/j.immuni.2009.04.011"/>
</citation>
<scope>UBIQUITINATION BY BIRC2 AND BIRC3</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-168; SER-363; SER-393; SER-527 AND SER-539</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2010" name="Genes Dev." volume="24" first="2666" last="2677">
<title>Inhibition of RIP2's tyrosine kinase activity limits NOD2-driven cytokine responses.</title>
<authorList>
<person name="Tigno-Aranjuez J.T."/>
<person name="Asara J.M."/>
<person name="Abbott D.W."/>
</authorList>
<dbReference type="PubMed" id="21123652"/>
<dbReference type="DOI" id="10.1101/gad.1964410"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT TYR-474</scope>
<scope>MUTAGENESIS OF TYR-474</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-529</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E22356" last="E22356">
<title>cIAP1/2 are direct E3 ligases conjugating diverse types of ubiquitin chains to receptor interacting proteins kinases 1 to 4 (RIP1-4).</title>
<authorList>
<person name="Bertrand M.J."/>
<person name="Lippens S."/>
<person name="Staes A."/>
<person name="Gilbert B."/>
<person name="Roelandt R."/>
<person name="De Medts J."/>
<person name="Gevaert K."/>
<person name="Declercq W."/>
<person name="Vandenabeele P."/>
</authorList>
<dbReference type="PubMed" id="21931591"/>
<dbReference type="DOI" id="10.1371/journal.pone.0022356"/>
</citation>
<scope>UBIQUITINATION BY BIRC2/C-IAP1 AND BIRC3/C-IAP2</scope>
<scope>INTERACTION WITH BIRC2/C-IAP1; BIRC3/C-IAP2 AND XIAP/BIRC4</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2012" name="Cell. Microbiol." volume="14" first="1568" last="1583">
<title>NLRP10 enhances Shigella-induced pro-inflammatory responses.</title>
<authorList>
<person name="Lautz K."/>
<person name="Damm A."/>
<person name="Menning M."/>
<person name="Wenger J."/>
<person name="Adam A.C."/>
<person name="Zigrino P."/>
<person name="Kremmer E."/>
<person name="Kufer T.A."/>
</authorList>
<dbReference type="PubMed" id="22672233"/>
<dbReference type="DOI" id="10.1111/j.1462-5822.2012.01822.x"/>
</citation>
<scope>INTERACTION WITH NLRP10</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2012" name="Inflamm. Bowel Dis." volume="18" first="603" last="612">
<title>Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1.</title>
<authorList>
<person name="Zhao Y."/>
<person name="Alonso C."/>
<person name="Ballester I."/>
<person name="Song J.H."/>
<person name="Chang S.Y."/>
<person name="Guleng B."/>
<person name="Arihiro S."/>
<person name="Murray P.J."/>
<person name="Xavier R."/>
<person name="Kobayashi K.S."/>
<person name="Reinecker H.C."/>
</authorList>
<dbReference type="PubMed" id="21887730"/>
<dbReference type="DOI" id="10.1002/ibd.21851"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH ARHGEF2 AND NOD2</scope>
<scope>INTERACTION WITH ARHGEF2 AND NOD2</scope>
<scope>PHOSPHORYLATION AT TYR-381</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-363; SER-527; SER-529 AND SER-531</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2013" name="Mol. Cell" volume="50" first="818" last="830">
<title>OTULIN restricts Met1-linked ubiquitination to control innate immune signaling.</title>
<authorList>
<person name="Fiil B.K."/>
<person name="Damgaard R.B."/>
<person name="Wagner S.A."/>
<person name="Keusekotten K."/>
<person name="Fritsch M."/>
<person name="Bekker-Jensen S."/>
<person name="Mailand N."/>
<person name="Choudhary C."/>
<person name="Komander D."/>
<person name="Gyrd-Hansen M."/>
</authorList>
<dbReference type="PubMed" id="23806334"/>
<dbReference type="DOI" id="10.1016/j.molcel.2013.06.004"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DEUBIQUITINATION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] THR-259; VAL-268 AND ASN-313</scope>
</reference>
<comment type="function">
<text evidence="14 16 18 22 23">Serine/threonine/tyrosine kinase that plays an essential role in modulation of innate and adaptive immune responses. Upon stimulation by bacterial peptidoglycans, NOD1 and NOD2 are activated, oligomerize and recruit RIPK2 through CARD-CARD domains. Contributes to the tyrosine phosphorylation of the guanine exchange factor ARHGEF2 through Src tyrosine kinase leading to NF-kappaB activation by NOD2. Once recruited, RIPK2 autophosphorylates and undergoes 'Lys-63'-linked polyubiquitination by E3 ubiquitin ligases XIAP, BIRC2 and BIRC3. The polyubiquitinated protein mediates the recruitment of MAP3K7/TAK1 to IKBKG/NEMO and induces 'Lys-63'-linked polyubiquitination of IKBKG/NEMO and subsequent activation of IKBKB/IKKB. In turn, NF-kappa-B is released from NF-kappa-B inhibitors and translocates into the nucleus where it activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis. Plays also a role during engagement of the T-cell receptor (TCR) in promoting BCL10 phosphorylation and subsequent NF-kappa-B activation.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="catalytic activity">
<text evidence="13">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="subunit">
<text evidence="16 18 19 21 23 24 25">Found in a signaling complex consisting of at least ARHGEF2, NOD2 and RIPK2. Interacts with ARHGEF2; the interaction mediates tyrosine phosphorylation of RIPK2 by Src kinase CSK. Binds to CFLAR/CLARP and CASP1 via their CARD domains. Binds to BIRC3/c-IAP1 and BIRC2/c-IAP2, TRAF1, TRAF2, TRAF5 and TRAF6. May be a component of both the TNFRSF1A and TNRFSF5/CD40 receptor complex. Interacts with NOD1. Interacts (via CARD domain) with NOD2 (via CARD domain). Interacts with MAP3K4; this interaction sequesters RIPK2 from the NOD2 signaling pathway. Interacts with IKBKG/NEMO. The polyubiquitinated protein interacts with MAP3K7/TAK1. Interacts with XIAP/BIRC4. Interacts with NLRP10. Interacts with CARD9.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358522"/>
<interactant intactId="EBI-358522"/>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358522"/>
<interactant intactId="EBI-514538">
<id>Q13490</id>
<label>BIRC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358522"/>
<interactant intactId="EBI-517709">
<id>Q13489</id>
<label>BIRC3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358522"/>
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
<label>MAVS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358522"/>
<interactant intactId="EBI-7445625">
<id>Q9HC29</id>
<label>NOD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358522"/>
<interactant intactId="EBI-357631">
<id>Q13114</id>
<label>TRAF3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358522"/>
<interactant intactId="EBI-517127">
<id>P98170</id>
<label>XIAP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="32">Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O43353-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O43353-2</id>
<name>2</name>
<sequence type="described" ref="VSP_013266"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Detected in heart, brain, placenta, lung, peripheral blood leukocytes, spleen, kidney, testis, prostate, pancreas and lymph node.</text>
</comment>
<comment type="domain">
<text>Contains an N-terminal kinase domain and a C-terminal caspase activation and recruitment domain (CARD) that mediates the recruitment of CARD-containing proteins.</text>
</comment>
<comment type="PTM">
<text evidence="15 22 23">Autophosphorylated. Autophosphorylation at Tyr-474 is necessary for effective NOD2 signaling. Phosphorylated. Phosphorylation at Tyr-381 by Src kinase CSK occurs in a ARHGEF2-dependent manner and is required for NOD2-dependent innate immune activation.</text>
</comment>
<comment type="PTM">
<text evidence="18 20 21 24 26">Ubiquitinated on Lys-209; undergoes 'Lys-63'-linked polyubiquitination catalyzed by ITCH. Polyubiquitinated with 'Lys-48' and 'Lys-63'-linked chains by BIRC2/c-IAP1 and BIRC3/c-IAP2, leading to activation of NF-kappa-B. Also undergoes 'Met-1'-linked polyubiquitination; the head-to-tail linear polyubiquitination is mediated by the LUBAC complex in response to NOD2 stimulation. Linear polyubiquitination is restricted by FAM105B/otulin, probably to limit NOD2-dependent proinflammatory signaling activation of NF-kappa-B.</text>
</comment>
<comment type="similarity">
<text evidence="32">Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family.</text>
</comment>
<dbReference type="EC" id="2.7.11.1"/>
<dbReference type="EC" id="2.7.10.2"/>
<dbReference type="EMBL" id="AF027706">
<property type="protein sequence ID" value="AAC34970.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF078530">
<property type="protein sequence ID" value="AAC27722.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF064824">
<property type="protein sequence ID" value="AAC25668.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY358813">
<property type="protein sequence ID" value="AAQ89172.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY358814">
<property type="protein sequence ID" value="AAQ89173.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK301448">
<property type="protein sequence ID" value="BAH13484.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC004003">
<property type="protein sequence ID" value="AAC24561.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF117829">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC004553">
<property type="protein sequence ID" value="AAH04553.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6247.1">
<molecule id="O43353-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003812.1">
<molecule id="O43353-1"/>
<property type="nucleotide sequence ID" value="NM_003821.5"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005251149.1">
<molecule id="O43353-2"/>
<property type="nucleotide sequence ID" value="XM_005251092.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.103755"/>
<dbReference type="PDB" id="2N7Z">
<property type="method" value="NMR"/>
<property type="chains" value="A=434-539"/>
</dbReference>
<dbReference type="PDB" id="2N83">
<property type="method" value="NMR"/>
<property type="chains" value="B=434-539"/>
</dbReference>
<dbReference type="PDB" id="4C8B">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="A/B=8-317"/>
</dbReference>
<dbReference type="PDB" id="5AR2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.44"/>
<property type="chains" value="A/B=1-310"/>
</dbReference>
<dbReference type="PDB" id="5AR3">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.23"/>
<property type="chains" value="A/B=1-310"/>
</dbReference>
<dbReference type="PDB" id="5AR4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=1-310"/>
</dbReference>
<dbReference type="PDB" id="5AR5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.66"/>
<property type="chains" value="A/B=1-310"/>
</dbReference>
<dbReference type="PDB" id="5AR7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.71"/>
<property type="chains" value="A/B=1-310"/>
</dbReference>
<dbReference type="PDB" id="5AR8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.79"/>
<property type="chains" value="A/B=1-310"/>
</dbReference>
<dbReference type="PDB" id="5J79">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.69"/>
<property type="chains" value="A/B=1-310"/>
</dbReference>
<dbReference type="PDB" id="5J7B">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.53"/>
<property type="chains" value="A/B=1-310"/>
</dbReference>
<dbReference type="PDBsum" id="2N7Z"/>
<dbReference type="PDBsum" id="2N83"/>
<dbReference type="PDBsum" id="4C8B"/>
<dbReference type="PDBsum" id="5AR2"/>
<dbReference type="PDBsum" id="5AR3"/>
<dbReference type="PDBsum" id="5AR4"/>
<dbReference type="PDBsum" id="5AR5"/>
<dbReference type="PDBsum" id="5AR7"/>
<dbReference type="PDBsum" id="5AR8"/>
<dbReference type="PDBsum" id="5J79"/>
<dbReference type="PDBsum" id="5J7B"/>
<dbReference type="ProteinModelPortal" id="O43353"/>
<dbReference type="SMR" id="O43353"/>
<dbReference type="BioGrid" id="114300">
<property type="interactions" value="44"/>
</dbReference>
<dbReference type="DIP" id="DIP-27518N"/>
<dbReference type="IntAct" id="O43353">
<property type="interactions" value="13"/>
</dbReference>
<dbReference type="MINT" id="MINT-90752"/>
<dbReference type="STRING" id="9606.ENSP00000220751"/>
<dbReference type="BindingDB" id="O43353"/>
<dbReference type="ChEMBL" id="CHEMBL5014"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2190"/>
<dbReference type="iPTMnet" id="O43353"/>
<dbReference type="PhosphoSitePlus" id="O43353"/>
<dbReference type="BioMuta" id="RIPK2"/>
<dbReference type="EPD" id="O43353"/>
<dbReference type="MaxQB" id="O43353"/>
<dbReference type="PaxDb" id="O43353"/>
<dbReference type="PeptideAtlas" id="O43353"/>
<dbReference type="PRIDE" id="O43353"/>
<dbReference type="DNASU" id="8767"/>
<dbReference type="Ensembl" id="ENST00000220751">
<molecule id="O43353-1"/>
<property type="protein sequence ID" value="ENSP00000220751"/>
<property type="gene ID" value="ENSG00000104312"/>
</dbReference>
<dbReference type="GeneID" id="8767"/>
<dbReference type="KEGG" id="hsa:8767"/>
<dbReference type="UCSC" id="uc003yee.4">
<molecule id="O43353-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="8767"/>
<dbReference type="DisGeNET" id="8767"/>
<dbReference type="GeneCards" id="RIPK2"/>
<dbReference type="HGNC" id="HGNC:10020">
<property type="gene designation" value="RIPK2"/>
</dbReference>
<dbReference type="HPA" id="HPA015273"/>
<dbReference type="HPA" id="HPA016499"/>
<dbReference type="MIM" id="603455">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O43353"/>
<dbReference type="OpenTargets" id="ENSG00000104312"/>
<dbReference type="PharmGKB" id="PA34395"/>
<dbReference type="eggNOG" id="KOG0192">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00550000074536"/>
<dbReference type="HOGENOM" id="HOG000136856"/>
<dbReference type="HOVERGEN" id="HBG054242"/>
<dbReference type="InParanoid" id="O43353"/>
<dbReference type="KO" id="K08846"/>
<dbReference type="OMA" id="PFEEVIN"/>
<dbReference type="OrthoDB" id="EOG091G0505"/>
<dbReference type="PhylomeDB" id="O43353"/>
<dbReference type="TreeFam" id="TF106506"/>
<dbReference type="BRENDA" id="2.7.10.2">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-168638">
<property type="pathway name" value="NOD1/2 Signaling Pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202424">
<property type="pathway name" value="Downstream TCR signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-209543">
<property type="pathway name" value="p75NTR recruits signalling complexes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-445989">
<property type="pathway name" value="TAK1 activates NFkB by phosphorylation and activation of IKKs complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-446652">
<property type="pathway name" value="Interleukin-1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-450302">
<property type="pathway name" value="activated TAK1 mediates p38 MAPK activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-450321">
<property type="pathway name" value="JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689896">
<property type="pathway name" value="Ovarian tumor domain proteases"/>
</dbReference>
<dbReference type="SignaLink" id="O43353"/>
<dbReference type="SIGNOR" id="O43353"/>
<dbReference type="ChiTaRS" id="RIPK2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="RIPK2"/>
<dbReference type="GenomeRNAi" id="8767"/>
<dbReference type="PRO" id="PR:O43353"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 8"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000104312"/>
<dbReference type="CleanEx" id="HS_RIPK2"/>
<dbReference type="ExpressionAtlas" id="O43353">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O43353">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005856">
<property type="term" value="C:cytoskeleton"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031982">
<property type="term" value="C:vesicle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0050700">
<property type="term" value="F:CARD domain binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0030274">
<property type="term" value="F:LIM domain binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004715">
<property type="term" value="F:non-membrane spanning protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004871">
<property type="term" value="F:signal transducer activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0000187">
<property type="term" value="P:activation of MAPK activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002250">
<property type="term" value="P:adaptive immune response"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0071223">
<property type="term" value="P:cellular response to lipoteichoic acid"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071225">
<property type="term" value="P:cellular response to muramyl dipeptide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071224">
<property type="term" value="P:cellular response to peptidoglycan"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050830">
<property type="term" value="P:defense response to Gram-positive bacterium"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007249">
<property type="term" value="P:I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007254">
<property type="term" value="P:JNK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031663">
<property type="term" value="P:lipopolysaccharide-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070427">
<property type="term" value="P:nucleotide-binding oligomerization domain containing 1 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070431">
<property type="term" value="P:nucleotide-binding oligomerization domain containing 2 signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070423">
<property type="term" value="P:nucleotide-binding oligomerization domain containing signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046641">
<property type="term" value="P:positive regulation of alpha-beta T cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032722">
<property type="term" value="P:positive regulation of chemokine production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001961">
<property type="term" value="P:positive regulation of cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0033091">
<property type="term" value="P:positive regulation of immature T cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032727">
<property type="term" value="P:positive regulation of interferon-alpha production"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032728">
<property type="term" value="P:positive regulation of interferon-beta production"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032729">
<property type="term" value="P:positive regulation of interferon-gamma production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032735">
<property type="term" value="P:positive regulation of interleukin-12 production"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032743">
<property type="term" value="P:positive regulation of interleukin-2 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032755">
<property type="term" value="P:positive regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046330">
<property type="term" value="P:positive regulation of JNK cascade"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033138">
<property type="term" value="P:positive regulation of peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010800">
<property type="term" value="P:positive regulation of peptidyl-threonine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050731">
<property type="term" value="P:positive regulation of peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031398">
<property type="term" value="P:positive regulation of protein ubiquitination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045627">
<property type="term" value="P:positive regulation of T-helper 1 cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032760">
<property type="term" value="P:positive regulation of tumor necrosis factor production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904417">
<property type="term" value="P:positive regulation of xenophagy"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043330">
<property type="term" value="P:response to exogenous dsRNA"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070555">
<property type="term" value="P:response to interleukin-1"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070671">
<property type="term" value="P:response to interleukin-12"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070673">
<property type="term" value="P:response to interleukin-18"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0042098">
<property type="term" value="P:T cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050852">
<property type="term" value="P:T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034134">
<property type="term" value="P:toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0034142">
<property type="term" value="P:toll-like receptor 4 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="InterPro" id="IPR001315">
<property type="entry name" value="CARD"/>
</dbReference>
<dbReference type="InterPro" id="IPR011029">
<property type="entry name" value="DEATH-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017322">
<property type="entry name" value="Rcpt-int_Ser/Thr_kinase-2"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00619">
<property type="entry name" value="CARD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037921">
<property type="entry name" value="STPK_RIP2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47986">
<property type="entry name" value="SSF47986"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50209">
<property type="entry name" value="CARD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-1064">Adaptive immunity</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Receptor-interacting serine/threonine-protein kinase 2" id="PRO_0000086608">
<location>
<begin position="1"/>
<end position="540"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="12">
<location>
<begin position="18"/>
<end position="294"/>
</location>
</feature>
<feature type="domain" description="CARD" evidence="11">
<location>
<begin position="432"/>
<end position="524"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="12">
<location>
<begin position="24"/>
<end position="32"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor">
<location>
<position position="146"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="47"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="168"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="15">
<location>
<position position="176"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 8 10">
<location>
<position position="363"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK" evidence="23">
<location>
<position position="381"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="393"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="22">
<location>
<position position="474"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 8 10">
<location>
<position position="527"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 10">
<location>
<position position="529"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 10">
<location>
<position position="531"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 8">
<location>
<position position="539"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="18">
<location>
<position position="209"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_013266" evidence="30 31">
<location>
<begin position="1"/>
<end position="137"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2230801." id="VAR_041045" evidence="17">
<original>I</original>
<variation>T</variation>
<location>
<position position="259"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35004667." id="VAR_041046" evidence="17">
<original>L</original>
<variation>V</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35395048." id="VAR_041047" evidence="17">
<original>K</original>
<variation>N</variation>
<location>
<position position="313"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity." evidence="27 28">
<original>K</original>
<variation>A</variation>
<location>
<position position="47"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces FAS-mediated apoptosis." evidence="27 28">
<original>K</original>
<variation>M</variation>
<location>
<position position="47"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity." evidence="29">
<original>D</original>
<variation>N</variation>
<location>
<position position="146"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of polyubiquitination." evidence="18">
<original>K</original>
<variation>R</variation>
<location>
<position position="209"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents phosphorylation. Reduces serine and threonine phosphorylation of ARHGEF2.">
<original>Y</original>
<variation>A</variation>
<location>
<position position="381"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with NOD1." evidence="16">
<original>R</original>
<variation>E</variation>
<location>
<position position="444"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases interaction with NOD2." evidence="22">
<original>Y</original>
<variation>F</variation>
<location>
<position position="474"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with NOD1." evidence="16">
<original>R</original>
<variation>E</variation>
<location>
<position position="483"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with NOD1." evidence="16">
<original>R</original>
<variation>E</variation>
<location>
<position position="488"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAH13484." ref="5" evidence="32">
<original>S</original>
<variation>G</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAH13484." ref="5" evidence="32">
<original>Q</original>
<variation>R</variation>
<location>
<position position="514"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="7"/>
<end position="9"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="15"/>
<end position="17"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="18"/>
<end position="25"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="31"/>
<end position="37"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="38"/>
<end position="40"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="43"/>
<end position="48"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="59"/>
<end position="72"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="81"/>
<end position="86"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="91"/>
<end position="96"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="103"/>
<end position="108"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="110"/>
<end position="112"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="118"/>
<end position="136"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="138"/>
<end position="140"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="149"/>
<end position="151"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="152"/>
<end position="154"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="160"/>
<end position="162"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="190"/>
<end position="192"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="195"/>
<end position="197"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="202"/>
<end position="204"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="210"/>
<end position="224"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="228"/>
<end position="231"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="235"/>
<end position="243"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="252"/>
<end position="254"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="262"/>
<end position="272"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="277"/>
<end position="279"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="283"/>
<end position="294"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="299"/>
<end position="307"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="436"/>
<end position="450"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="453"/>
<end position="465"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="471"/>
<end position="476"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="483"/>
<end position="497"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="501"/>
<end position="511"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="526"/>
<end position="528"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="530"/>
<end position="532"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2N7Z"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2N83"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5AR2"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5AR4"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5J79"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00046"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14638696"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16824733"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17054981"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18079694"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18775659"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19464198"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19592251"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21123652"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21887730"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21931591"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22672233"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23806334"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9575181"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9642260"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9705938"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12975309"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000305"/>
<sequence length="540" mass="61195" checksum="575A692239505792" modified="1998-11-01" version="2">
MNGEAICSALPTIPYHKLADLRYLSRGASGTVSSARHADWRVQVAVKHLHIHTPLLDSER
KDVLREAEILHKARFSYILPILGICNEPEFLGIVTEYMPNGSLNELLHRKTEYPDVAWPL
RFRILHEIALGVNYLHNMTPPLLHHDLKTQNILLDNEFHVKIADFGLSKWRMMSLSQSRS
SKSAPEGGTIIYMPPENYEPGQKSRASIKHDIYSYAVITWEVLSRKQPFEDVTNPLQIMY
SVSQGHRPVINEESLPYDIPHRARMISLIESGWAQNPDERPSFLKCLIELEPVLRTFEEI
TFLEAVIQLKKTKLQSVSSAIHLCDKKKMELSLNIPVNHGPQEESCGSSQLHENSGSPET
SRSLPAPQDNDFLSRKAQDCYFMKLHHCPGNHSWDSTISGSQRAAFCDHKTTPCSSAIIN
PLSTAGNSERLQPGIAQQWIQSKREDIVNQMTEACLNQSLDALLSRDLIMKEDYELVSTK
PTRTSKVRQLLDTTDIQGEEFAKVIVQKLKDNKQMGLQPYPEILVVSRSPSLNLLQNKSM
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>